These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 26436854

  • 1. Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
    Ramroodi N, Khani M, Ganjali Z, Javan MR, Sanadgol N, Khalseh R, Ravan H, Sanadgol E, Abdollahi M.
    Immunol Invest; 2015; 44(7):694-712. PubMed ID: 26436854
    [Abstract] [Full Text] [Related]

  • 2. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
    Lee JH, Halperin-Sheinfeld M, Baatar D, Mughal MR, Tae HJ, Kim JW, Carter A, Lustig A, Snir O, Lavie G, Okun E, Mattson MP, Sredni B, Taub DD.
    Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K, Pankratz S, Schneider-Hohendorf T, Bittner S, Schuhmann MK, Langer HF, Stoll G, Wiendl H, Kleinschnitz C, Meuth SG.
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [Abstract] [Full Text] [Related]

  • 5. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S, Périnat T, Greene G, Enzmann G, Deutsch U, Adams R, Imhof B, Aurrand-Lions M, Engelhardt B.
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [Abstract] [Full Text] [Related]

  • 6. Adhesion Molecule Profile and the Effect of Anti-VLA-4 mAb Treatment in Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple Sclerosis.
    Pyka-Fościak G, Lis GJ, Litwin JA.
    Int J Mol Sci; 2022 Apr 22; 23(9):. PubMed ID: 35563027
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
    Berghmans N, Heremans H, Li S, Martens E, Matthys P, Sorokin L, Van Damme J, Opdenakker G.
    J Neuroinflammation; 2012 Oct 25; 9():243. PubMed ID: 23095573
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b+ myeloid cells.
    Arellano G, Acuña E, Loda E, Moore L, Tichauer JE, Castillo C, Vergara F, Burgos PI, Penaloza-MacMaster P, Miller SD, Naves R.
    J Neuroinflammation; 2024 May 31; 21(1):144. PubMed ID: 38822334
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M, Li YT, Sorokin L, Rottner K, Vestweber D.
    J Neurosci; 2020 Feb 12; 40(7):1389-1404. PubMed ID: 31911458
    [Abstract] [Full Text] [Related]

  • 12. CKD-506: A novel HDAC6-selective inhibitor that exerts therapeutic effects in a rodent model of multiple sclerosis.
    Bae D, Lee JY, Ha N, Park J, Baek J, Suh D, Lim HS, Ko SM, Kim T, Som Jeong D, Son WC.
    Sci Rep; 2021 Jul 14; 11(1):14466. PubMed ID: 34262061
    [Abstract] [Full Text] [Related]

  • 13. Epithelial V-like antigen mediates efficacy of anti-alpha₄ integrin treatment in a mouse model of multiple sclerosis.
    Wright E, Rahgozar K, Hallworth N, Lanker S, Carrithers MD.
    PLoS One; 2013 Jul 14; 8(8):e70954. PubMed ID: 23951051
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
    Duan RN, Yang CL, Du T, Liu A, Wang AR, Sun WJ, Li X, Li JX, Yan CZ, Liu QJ.
    J Neuroinflammation; 2021 Jun 28; 18(1):145. PubMed ID: 34183017
    [Abstract] [Full Text] [Related]

  • 16. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z, Haghmorad D, Sankian M, Rastin M, Nosratabadi R, Soltan Dallal MM, Tabasi N, Khazaee M, Nasiraii LR, Mahmoudi M.
    Biomed Pharmacother; 2017 Nov 28; 95():1535-1548. PubMed ID: 28946394
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells.
    Alabanza LM, Esmon NL, Esmon CT, Bynoe MS.
    J Immunol; 2013 Oct 01; 191(7):3764-77. PubMed ID: 23997223
    [Abstract] [Full Text] [Related]

  • 18. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J, Wingerath B, Graf J, Lepka K, Hofrichter M, Schröter F, Wedekind F, Bauer A, Schrader J, Hartung HP, Prozorovski T, Aktas O.
    J Neuroinflammation; 2016 Feb 26; 13():48. PubMed ID: 26920550
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.
    Aarts SABM, Seijkens TTP, Kusters PJH, van der Pol SMA, Zarzycka B, Heijnen PDAM, Beckers L, den Toom M, Gijbels MJJ, Boon L, Weber C, de Vries HE, Nicolaes GAF, Dijkstra CD, Kooij G, Lutgens E.
    J Neuroinflammation; 2017 May 12; 14(1):105. PubMed ID: 28494768
    [Abstract] [Full Text] [Related]

  • 20. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
    Sonobe Y, Jin S, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A.
    Tohoku J Exp Med; 2007 Dec 12; 213(4):329-39. PubMed ID: 18075237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.